Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Synthesis and antifungal activity of pradimicin derivatives. Modifications on the aglycone part.

Aburaki S, Okuyama S, Hoshi H, Kamachi H, Nishio M, Hasegawa T, Masuyoshi S, Iimura S, Konishi M, Oki T.

J Antibiot (Tokyo). 1993 Sep;46(9):1447-57.

2.

Antifungal activities of pradimicin derivatives modified at C4'-amino group.

Kamachi H, Okuyama S, Hirano M, Masuyoshi S, Konishi M, Oki T.

J Antibiot (Tokyo). 1993 Aug;46(8):1246-51.

3.

BU-4794F, a new beta-1,3-glucan synthase inhibitor.

Aoki M, Andoh T, Ueki T, Masuyoshi S, Sugawara K, Oki T.

J Antibiot (Tokyo). 1993 Jun;46(6):952-60.

4.

Synthesis and antibacterial activity of cephalosporins having a catechol in the C3 side chain.

Okita T, Imae K, Hasegawa T, Iimura S, Masuyoshi S, Kamachi H, Kamei H.

J Antibiot (Tokyo). 1993 May;46(5):833-9.

5.

Beta-cyanoglutamic acid, a new antifungal amino acid from a streptomycete.

Naruse N, Yamamoto S, Yamamoto H, Kondo S, Masuyoshi S, Numata K, Fukagawa Y, Oki T.

J Antibiot (Tokyo). 1993 Apr;46(4):685-6. No abstract available.

6.

Synthesis and antifungal activity of pradimicin derivatives. Modifications of the sugar part.

Aburaki S, Yamashita Y, Ohnuma T, Kamachi H, Moriyama T, Masuyoshi S, Kamei H, Konishi M, Oki T.

J Antibiot (Tokyo). 1993 Apr;46(4):631-40.

7.

In vitro and in vivo antifungal activities of BMS-181184.

Oki T, Kakushima M, Hirano M, Takahashi A, Ohta A, Masuyoshi S, Hatori M, Kamei H.

J Antibiot (Tokyo). 1992 Sep;45(9):1512-7. No abstract available.

8.

In vitro and in vivo antifungal activities of BMY-28864, a water-soluble pradimicin derivative.

Kakushima M, Masuyoshi S, Hirano M, Shinoda M, Ohta A, Kamei H, Oki T.

Antimicrob Agents Chemother. 1991 Nov;35(11):2185-90.

9.

Synthesis and activity of butirosin derivatives with 5''-amidino and 5''-guanidino substituents.

Narita Y, Masuyoshi S, Yamasaki T, Naito T, Kawaguchi H.

J Antibiot (Tokyo). 1991 Jan;44(1):86-92.

10.

In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters.

Tomatsu K, Masuyoshi S, Hirano M, Kawaguchi H, Oki T, Fung-Tomc J, Desiderio JV, Kessler RE.

Antimicrob Agents Chemother. 1989 Apr;33(4):489-97.

11.

Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.

Masuyoshi S, Hiraoka M, Inoue M, Tomatsu K, Hirano M, Mitsuhashi S.

Drugs Exp Clin Res. 1989;15(1):1-10.

PMID:
2663406
12.
13.

Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.

Hiraoka M, Masuyoshi S, Mitsuhashi S, Tomatsu K, Inoue M.

J Antibiot (Tokyo). 1988 Jan;41(1):86-93.

14.

In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.

Hiraoka M, Masuyoshi S, Tomatsu K, Inoue M, Mitsuhashi S.

Eur J Clin Microbiol. 1987 Oct;6(5):559-63.

PMID:
3501756
15.

In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.

Tomatsu K, Ando S, Masuyoshi S, Kondo S, Hirano M, Miyaki T, Kawaguchi H.

J Antibiot (Tokyo). 1987 Aug;40(8):1175-83.

16.
17.

Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin.

Tomatsu K, Ando S, Masuyoshi S, Hirano M, Miyaki T, Kawaguchi H.

J Antibiot (Tokyo). 1986 Nov;39(11):1584-91.

18.

In vivo antibacterial activity of cefodizime, a new cephalosporin antibiotic.

Kasai K, Tsuji A, Miyazaki S, Goto S, Fujimoto K, Masuyoshi S, Arai S.

Jpn J Antibiot. 1984 Jul;37(7):1306-12.

PMID:
6092740
19.

In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.

Kasai K, Tsuji A, Miyazaki S, Goto S, Fujimoto K, Masuyoshi S, Arai S.

Jpn J Antibiot. 1984 Jul;37(7):1294-305.

PMID:
6092739
20.

[Study of cefotaxime on stability to beta-lactamases and affinity to penicillin-binding proteins].

Inoue M, Masuyoshi S, Mitsuhashi S.

Jpn J Antibiot. 1983 Jan;36(1):117-23. Japanese.

PMID:
6302343
21.

Cefotaxime: binding affinity to penicillin-binding proteins and morphological changes of Escherichia coli and Pseudomonas aeruginosa.

Masuyoshi S, Inoue M, Takaoka M, Mitsuhashi S.

Arzneimittelforschung. 1981;31(7):1070-2.

PMID:
6268122
22.

Antibacterial activity of cefotaxime.

Mitsuhashi S, Inoue M, Masuyoshi S.

J Antimicrob Chemother. 1980 Sep;6 Suppl A:37-46. No abstract available.

PMID:
6252177
23.

In vitro antimicrobial activity of cefotaxime, a new cephalosporin.

Masuyoshi S, Arai S, Miyamoto M, Mitsuhashi S.

Antimicrob Agents Chemother. 1980 Jul;18(1):1-8.

Supplemental Content

Loading ...
Support Center